Thursday, January 24, 2019 10:16:24 AM
TransCanna Inc. is pleased to announce that the Frankfurt Stock Exchange (XETR) has approved the Company for trading on their exchange. The Company’s Frankfurt listing is TH8, according to the Cannabis Investor.
Additionally, the company has engaged Purple Crown Communications for a term of twelve months, renewable on a monthly basis thereafter on mutual agreement. Purple Crown’s appointment as an investor relations consultant to TransCanna is subject to regulatory approval of applicable filings with the Canadian Securities Exchange.
According to the CEO of TransCanna, Jim Pakulis, “Our goal was to align ourselves with a firm that puts shareholder communication first and can build a strong shareholder base as management focuses on building the business.? We’re extremely pleased to have retained Purple Crown, and we look forward to working with them and growing TransCanna together.”
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM